证券记录 · 已归档季度
ALC
Alcon Inc. · Healthcare · Medical - Specialties
18被追踪持有人
+1Δ持有人
56.88M持有股份
$4.25B报告持仓市值
+3新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 +5.9% ·
股份流向 +0.8% ·
净新建仓位 0.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 98.31K | $6.32M | n/a | n/a |
| Q2 2026 | 127 | 0 | 163.63M | $10.97B | +8 | −7 |
| Q1 2026 | 128 | -2 | 149.67M | $11.22B | +4 | −7 |
| Q4 2025 | 130 | +1 | 168.20M | $13.30B | +2 | n/a |
| Q3 2025 | 18 | +1 | 56.88M | $4.25B | +3 | −3 |
| Q2 2025 | 15 | -4 | 57.20M | $5.06B | n/a | −4 |
| Q1 2025 | 16 | +1 | 22.35M | $2.11B | +1 | n/a |
| Q4 2024 | 15 | +2 | 21.30M | $1.81B | +3 | −1 |
| Q3 2024 | 12 | 0 | 17.31M | $1.73B | +2 | −2 |
| Q2 2024 | 12 | n/a | 18.62M | $1.66B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 21.20M | +1.6% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | Fidelity (FMR) ✦ | 10.74M | -23.3% | $799.19M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 3 | T. Rowe Price ✦ | 10.26M | +46.9% | $764.14M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | JPMorgan Chase ✦ | 5.36M | n/a | $399.48M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 5 | Goldman Sachs Group ✦ | 3.05M | n/a | $227.19M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 6 | Morgan Stanley ✦ | 2.18M | n/a | $162.79M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 7 | PRIMECAP Management ✦ | 1.34M | -0.8% | $100.21M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 736.15K | -58.8% | $54.85M | 0.0% | ▼ Trim | 2 | SEC ↗ ×7 |
| 9 | Marshall Wace ✦ | 706.23K | +40.6% | $52.60M | 0.1% | ▲ Add | 6 | SEC ↗ ×4 |
| 10 | Point72 Asset Management ✦ | 522.80K | 新增 | $38.95M | 0.1% | New | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 227.55K | 新增 | $16.95M | 0.0% | New | 1 | SEC ↗ ×2 |
| 12 | Arrowstreet Capital ✦ | 216.06K | +1119.0% | $16.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Millennium Management ✦ | 159.57K | 新增 | $11.89M | 0.0% | New | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 96.58K | -25.5% | $7.19M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Two Sigma Investments ✦ | 65.98K | -52.9% | $4.92M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 11.83K | +43.1% | $881,306 | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | State Street Global Advisors ✦ (被动) | 6.12K | 0.0% | $456,225 | 0.0% | Held | 4 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 5.88K | -11.8% | $438,278 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $38.95M | 0.1% |
| Citadel Advisors | $16.95M | 0.0% |
| Millennium Management | $11.89M | 0.0% |
已清仓
| Norges Bank | $1.00B | 曾为 0.1% |
| Adage Capital Partners | $3.44M | 曾为 0.0% |
| D. E. Shaw & Co. | $1.11M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 653 持有人, 227.25M 股份, $16.12B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据